Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer

Gynecologic Oncology

Volumn 123, Issue 1, 2011, Pages 99-104

  Ying, Xiong ^a   Li Zhi, Liang ^a   Li Ping, Cao ^a   Min, Zheng ^a   Ji Hong, Liu ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Cervix neoplasm; Cisplatin; Drug therapy; Irinotecan hydrochloride; Neoadjuvant therapy

Indexed keywords

CISPLATIN; IRINOTECAN; TROPISETRON;

ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROPENIA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LEUKOPENIA; LIVER TOXICITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; TREATMENT RESPONSE; UTERINE CERVIX CANCER;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 80052566957     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.06.011     Document Type: Article

References (23)

1. WHO World Health Organization Report: Comprehensive Cervical Cancer Control: a Guide to Essential Practice. World Health Organization Web site Available at www.who.int/reproductive-health/publications/cervical-cancer-gep/ index.htm 2006 Accessed on February 2008
2. R.P. Hertzberg, M.J. Caranfa, and S.M. Hecht On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex Biochemistry 28 11 1989 4629 4638 (Pubitemid 19151036)
3. T. Sugiyama, T. Nishida, and S. Kumagai Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer Br J Cancer 81 1999 95 98 (Pubitemid 29415497)
4. T. Kunimoto, K. Nitta, and T. Tanaka Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy-camptothec in, a novel water-soluble derivative of camptothecin, against murine tumors Cancer Res 47 22 1987 5944 5947 (Pubitemid 18018734)
5. S. Takeuchi, K. Dobashi, and S. Fujimoto A late phase II study of CPT-11 on uterine cervical cancer and ovarian cancer. Research Groups of CPT-11 in Gynecologic Cancers Gan To Kagaku Ryoho 18 10 1991 1681 1689
6. T. Sugiyama, S. Takeuchi, and K. Noda Phase I study of irinotecan (CPT-11) in combination with cisplatin in cervical cancer Pro Am Soc Clin Oncol 13 1995 A1546
7. Y.C. Wang, D. Ma, and T. Zhu Clinical effects of combination chemotherapy with irinotecan hydrochloride and cisplatin on cervical cancer Chin Acad J 85 30 2005 2104 2108 (Pubitemid 41179453)
8. T. Shoji, E. Takatori, and M. Murai Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT-11 for locally advanced cervical cancer Gan To Kagaku Ryoho 37 4 2010 643 648
9. S.E. Namkoong, J.S. Park, and J.W. Kim Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy Gynecol Oncol 59 1 1995 136 142
10. H.B. Cai, H.Z. Chen, and H.H. Yin Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer J Obstet Gynecol Res 32 2006 315 323
11. G.T. Eddy, Ban Bundy, and W.T. Creasman Treatment of "bulky" stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group Gynecol Oncol 106 2007 362 369 (Pubitemid 47087936)
12. H. Chen, C. Liang, and L. Zhang Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study Gynecol Oncol 110 3 2008 308 315
13. Y.H. Cho, D.Y. Kim, and J.H. Kim Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer J Gynecol Oncol 20 2009 22 27
14. M. Matsumura, N. Takeshima, and T. Ota Neoadjuvant chemotherapy followed by radical hysterectomy plus postoperative chemotherapy but no radiotherapy for Stage IB2-IIB cervical cancer-irinotecan and platinum chemotherapy Gynecol Oncol 119 2 2010 212 216
15. P. Benedetti-Panici, S. Greggi, and A. Colombo Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study J Clin Oncol 20 2002 179 188 (Pubitemid 34032610)
16. J.E. Sardi, C.E. Sananes, and A.A. Gioaroli Neoadjuvant chemotherapy in cervical carcinoma Stage IIb: a randomized controlled trial Int J Gynecol Cancer 8 1998 441 450 (Pubitemid 29028825)
17. L. Rydzewska, J. Tierney, and C.L. Vale Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer Cochrane Database Syst Rev 1 2010 CD007406.
18. J.R. van Nagell, Rayburn W. Jr, and E.S. Donaldson Therapeutic implications of patterns of recurrence in cancer of the uterine cervix Cancer 44 6 1979 2354 2361 (Pubitemid 10210871)
19. P. Benedetti Panici, M.A. Zullo, and L. Muzii The role of neoadjuvant chemotherapy followed by radical surgery in the treatment of locally advanced cervical cancer Eur J Gynecol Oncol 24 2003 467 470 (Pubitemid 37474050)
20. A. González-Martín, L. González-Cortijo, and N. Carballo The current role of neoadjuvant chemotherapy in the management of cervical carcinoma Gynecol Oncol 110 3 Suppl 2 2008 S36 S40
21. H.J. Huang, T.C. Chang, and J.H. Hong et al. Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (> / = 4 cm) stage Ib and IIa cervical carcinoma Int J Gynecol Cancer 13 2003 204 211
22. R. Fujiwaki, K. Iida, and Y. Ohnishi Intra-arterial neoadjuvant chemotherapy followed by radical surgery and radiotherapy for stage IIb cervical carcinoma Anticancer Res 17 5B 1997 3751 3755 (Pubitemid 28014934)
23. L. Fuso, S. Mazzola, and F. Marocco Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report Gynecol Oncol 99 3 Suppl 1 2005 S187 S191